ATE102832T1 - Regionale chemotherapie mit 4hydroperoxycyclophosphamid. - Google Patents
Regionale chemotherapie mit 4hydroperoxycyclophosphamid.Info
- Publication number
- ATE102832T1 ATE102832T1 AT90905145T AT90905145T ATE102832T1 AT E102832 T1 ATE102832 T1 AT E102832T1 AT 90905145 T AT90905145 T AT 90905145T AT 90905145 T AT90905145 T AT 90905145T AT E102832 T1 ATE102832 T1 AT E102832T1
- Authority
- AT
- Austria
- Prior art keywords
- regional chemotherapy
- tumors
- hydroperoxycyclophosphamide
- regionally
- cytolytic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32892189A | 1989-03-27 | 1989-03-27 | |
PCT/US1990/001298 WO1990011078A2 (en) | 1989-03-27 | 1990-03-16 | Regional chemotherapy with 4-hydroperoxycyclophosphamide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE102832T1 true ATE102832T1 (de) | 1994-04-15 |
Family
ID=23283049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90905145T ATE102832T1 (de) | 1989-03-27 | 1990-03-16 | Regionale chemotherapie mit 4hydroperoxycyclophosphamid. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5407925A (de) |
EP (2) | EP0465512B1 (de) |
JP (1) | JPH04505757A (de) |
AT (1) | ATE102832T1 (de) |
AU (1) | AU642868B2 (de) |
CA (1) | CA2049341C (de) |
DE (1) | DE69007472T2 (de) |
DK (1) | DK0465512T3 (de) |
ES (1) | ES2062517T3 (de) |
WO (1) | WO1990011078A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251886B1 (en) | 1998-12-07 | 2001-06-26 | Schering Corporation | Methods of using temozolomide in the treatment of cancers |
US6545034B1 (en) * | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA955937A (en) * | 1971-06-28 | 1974-10-08 | Shionogi And Co. Ltd. | Cyclic phosphamide derivatives |
-
1990
- 1990-03-16 AU AU53374/90A patent/AU642868B2/en not_active Ceased
- 1990-03-16 DK DK90905145.0T patent/DK0465512T3/da active
- 1990-03-16 JP JP2505078A patent/JPH04505757A/ja active Pending
- 1990-03-16 DE DE69007472T patent/DE69007472T2/de not_active Expired - Fee Related
- 1990-03-16 EP EP90905145A patent/EP0465512B1/de not_active Expired - Lifetime
- 1990-03-16 EP EP19930106295 patent/EP0567031A1/de not_active Withdrawn
- 1990-03-16 AT AT90905145T patent/ATE102832T1/de not_active IP Right Cessation
- 1990-03-16 CA CA002049341A patent/CA2049341C/en not_active Expired - Lifetime
- 1990-03-16 ES ES90905145T patent/ES2062517T3/es not_active Expired - Lifetime
- 1990-03-16 WO PCT/US1990/001298 patent/WO1990011078A2/en active Search and Examination
-
1991
- 1991-11-06 US US07/788,609 patent/US5407925A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU5337490A (en) | 1990-10-22 |
EP0567031A1 (de) | 1993-10-27 |
WO1990011078A2 (en) | 1990-10-04 |
ES2062517T3 (es) | 1994-12-16 |
DE69007472D1 (en) | 1994-04-21 |
WO1990011078A8 (en) | 2005-06-16 |
JPH04505757A (ja) | 1992-10-08 |
DK0465512T3 (da) | 1994-05-30 |
EP0465512B1 (de) | 1994-03-16 |
DE69007472T2 (de) | 1994-07-14 |
CA2049341C (en) | 2001-02-20 |
CA2049341A1 (en) | 1990-09-28 |
EP0465512A1 (de) | 1992-01-15 |
US5407925A (en) | 1995-04-18 |
AU642868B2 (en) | 1993-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ2000531A3 (en) | Method of prevention or therapy of estrogen-dependent diseases and disorders | |
MX150494A (es) | Mejoras en aparato de calentamiento localmente definido y selectivo para el tratamiento de un cuerpo humano en la destruccion de celulas corporeas o tumores malignos | |
DE3481893D1 (de) | Hyperthermie-apparat. | |
ZA921911B (en) | 2,4-diaminoquinazoline derivatives for enhancing anti-tumor activity. | |
GR3034535T3 (en) | Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer | |
ATE288776T1 (de) | Ausdehnbare vorrichtung zur behandlung von tumoren | |
ATE425749T1 (de) | Behandlung von mit her-2/neu-uberexprimierung einhergehendem krebs | |
ATE479443T1 (de) | Chimärer anti-cd20 antikörper, rituxan, zur verwendung in der behandlung der chronischen lymphatischen leukemie | |
HUP0102793A3 (en) | Quinazolines for treating brain tumor and medicaments containing them | |
DE69715000D1 (de) | Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens | |
HK1022810A1 (en) | Method of treating endothelial injury | |
NZ504928A (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
SG45366A1 (en) | Method of treating and/or diagonising soft tissue tumors | |
ATE102832T1 (de) | Regionale chemotherapie mit 4hydroperoxycyclophosphamid. | |
ATE243522T1 (de) | Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren | |
DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
EP0938900A4 (de) | Mittel zur vorbeugung bzw. heilung der stomatitis | |
Dougherty | Future of photoradiation therapy in the treatment of cancer. | |
GB9625193D0 (en) | Treatment of highly vascular tumours | |
DE59009724D1 (de) | Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen. | |
DE58904510D1 (de) | Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen. | |
DE3064274D1 (en) | 2,3,4,5,6-penta-o-acetyl-d-gluconyl isothiocyanate for use in preventing and treating cancer | |
BG34201A1 (en) | Method for potentiating the effect of cytostatic agents in chemical treatment of cancer | |
UA31314A (uk) | Спосіб лікування облисіння та пристрій для його здійснення |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |